Rezurock 200 mg Tablet is an FDA-approved prescription medicine containing Belumosudil, a targeted kinase inhibitor used in the treatment of chronic graft-versus-host disease (cGVHD). It is recommended for patients 12 years and older who have previously received at least two lines of systemic therapy without sufficient response. Rezurock works by selectively inhibiting the ROCK2 (R... https://www.drugsgeneral.com/rezurock-200-mg-tablet/